153 related articles for article (PubMed ID: 17372278)
1. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
Hodgson DC; Gilbert ES; Dores GM; Schonfeld SJ; Lynch CF; Storm H; Hall P; Langmark F; Pukkala E; Andersson M; Kaijser M; Joensuu H; Fosså SD; Travis LB
J Clin Oncol; 2007 Apr; 25(12):1489-97. PubMed ID: 17372278
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
Castellino SM; Geiger AM; Mertens AC; Leisenring WM; Tooze JA; Goodman P; Stovall M; Robison LL; Hudson MM
Blood; 2011 Feb; 117(6):1806-16. PubMed ID: 21037086
[TBL] [Abstract][Full Text] [Related]
3. Risk of male breast cancer after Hodgkin lymphoma.
de Vries S; Krul IM; Schaapveld M; Janus CPM; Rademakers SE; Roesink JM; Nijziel MR; Bilgin YM; Aleman BMP; van Leeuwen FE
Blood; 2023 Aug; 142(9):806-811. PubMed ID: 37390297
[TBL] [Abstract][Full Text] [Related]
4. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
Meadows AT; Friedman DL; Neglia JP; Mertens AC; Donaldson SS; Stovall M; Hammond S; Yasui Y; Inskip PD
J Clin Oncol; 2009 May; 27(14):2356-62. PubMed ID: 19255307
[TBL] [Abstract][Full Text] [Related]
5. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
6. Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities.
Lyu M; Luo L; Zhou L; Feng X; Yang J; Xu Z; Sun X; Bao Z; Wang X; Gao B; Xiang Y
Cancer Cell Int; 2024 Feb; 24(1):84. PubMed ID: 38402182
[TBL] [Abstract][Full Text] [Related]
7. Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma.
Geurts YM; Neppelenbroek SIM; Aleman BMP; Janus CPM; Krol ADG; van Spronsen DJ; Plattel WJ; Roesink JM; Verschueren KMS; Zijlstra JM; Koene HR; Nijziel MR; Schimmel EC; de Jongh E; Ong F; Te Boome LCJ; van Rijn RS; Böhmer LH; Ta BDP; Visser HPJ; Posthuma EFM; Bilgin YM; Muller K; van Kampen D; So-Osman C; Vermaat JSP; de Weijer RJ; Kersten MJ; van Leeuwen FE; Schaapveld M
ESMO Open; 2024 Feb; 9(2):102248. PubMed ID: 38350338
[TBL] [Abstract][Full Text] [Related]
8. Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks.
Singh P; Agnese D; Amin M; Barrio AV; Botty Van den Bruele A; Burke E; Danforth DN; Dirbas FM; Eladoumikdachi F; Kantor O; Kumar S; Lee MC; Matsen C; Nguyen TT; Ozmen T; Park KU; Plichta JK; Reyna C; Showalter SL; Styblo T; Tranakas N; Weiss A; Laronga C; Boughey J
Ann Surg Oncol; 2024 Apr; 31(4):2212-2223. PubMed ID: 38261126
[TBL] [Abstract][Full Text] [Related]
9. Management of limited-stage Hodgkin lymphoma.
Al-Juhaishi T; Ahmed S
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):500-509. PubMed ID: 38066938
[TBL] [Abstract][Full Text] [Related]
10. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
[TBL] [Abstract][Full Text] [Related]
11. Occupational exposure to asbestos in the steel industry (1972-2006).
Paustenbach DJ; Stevens ME; Tuttle BP; Shore RA; Ligas S; Brew DW
J Expo Sci Environ Epidemiol; 2023 Jul; ():. PubMed ID: 37495866
[TBL] [Abstract][Full Text] [Related]
12. Multi-Phenotypic Breast Cancer Post-Radiotherapy for Hodgkin Lymphoma: A Case of Secondary Malignancy.
White D; Sadough Shahmirzadi M; Boulmay B
J Investig Med High Impact Case Rep; 2023; 11():23247096231188251. PubMed ID: 37480256
[TBL] [Abstract][Full Text] [Related]
13. Reply: Radiopharmaceutical Extravasations CanHave Consequences.
Parihar AS; Raymond-Schmidt L; Crandall JP; Dehdashti F; Wahl RL
J Nucl Med; 2023 Aug; 64(8):1324-1325. PubMed ID: 37385671
[No Abstract] [Full Text] [Related]
14. Concurrent Splenic Marginal Zone B Cell Lymphoma and Metastatic Pancreatic Adenocarcinoma Diagnosed on Splenectomy for Suspected Splenic Abscess.
Fernandez K; Cheung LH; Balasinkam S; Taddesse-Heath L
Cureus; 2023 Feb; 15(2):e35541. PubMed ID: 37007330
[TBL] [Abstract][Full Text] [Related]
15. Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy.
Ykema BLM; Gini A; Rigter LS; Spaander MCW; Moons LMG; Bisseling TM; de Boer JP; Verbeek WHM; Lugtenburg PJ; Janus CPM; Petersen EJ; Roesink JM; van der Maazen RWM; ; Aleman BMP; Meijer GA; van Leeuwen FE; Snaebjornsson P; Carvalho B; van Leerdam ME; Lansdorp-Vogelaar I
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2157-2168. PubMed ID: 36166472
[TBL] [Abstract][Full Text] [Related]
17. Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression.
Ochoa-Grullón J; Guevara-Hoyer K; Pérez López C; Pérez de Diego R; Peña Cortijo A; Polo M; Mateo Morales M; Anguita Mandley E; Jiménez García C; Bolaños E; Íñigo B; Medina F; Rodríguez de la Peña A; Izquierdo Delgado C; de la Fuente Muñoz E; Mayol E; Fernández-Arquero M; González-Fernández A; Benavente Cuesta C; Sánchez-Ramón S
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009567
[TBL] [Abstract][Full Text] [Related]
18. Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.
Dubois F; Bazille C; Levallet J; Maille E; Brosseau S; Madelaine J; Bergot E; Zalcman G; Levallet G
Target Oncol; 2022 Jul; 17(4):407-431. PubMed ID: 35906513
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.
Rigter LS; Snaebjornsson P; Rosenberg EH; Altena E; van Grieken NCT; Aleman BMP; Kerst JM; Morton L; Schaapveld M; Meijer GA; van Leeuwen FE; van Leerdam ME;
PLoS One; 2022; 17(7):e0270591. PubMed ID: 35877698
[TBL] [Abstract][Full Text] [Related]
20. Cancer incidence in healthy Swedish peripheral blood stem cell donors.
Pahnke S; Nygell UA; Johansson JE; Kisch A; Ljungman P; Sandstedt A; Hägglund H; Larfors G
Bone Marrow Transplant; 2022 May; 57(5):795-802. PubMed ID: 35256742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
